Evidence map›Paper›PMID 29231845›Full record

ReviewInternational journal of molecular sciences2017

Maillard Proteomics: Opening New Pages.

Alena Soboleva, Rico Schmidt, Maria Vikhnina, Tatiana Grishina, Andrej Frolov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Food Peptides for the Nutricosmetic Industry.Antioxidants (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Desiccation Tolerance as the Basis of Long-Term Seed Viability.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Proteome Map of Pea (International journal of molecular sciences · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alena SobolevaDepartment of Biochemistry, St. Petersburg State University, Saint Petersburg 199034, Russia. st021585@student.spbu.ru.
Rico SchmidtDepartment of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin-Luther Universität Halle-Wittenberg, 06108 Halle, Germany. rico.schmidt@pharmazie.uni-halle.de.
Maria VikhninaDepartment of Biochemistry, St. Petersburg State University, Saint Petersburg 199034, Russia. m.vikhnina@spbu.ru.
Tatiana GrishinaDepartment of Biochemistry, St. Petersburg State University, Saint Petersburg 199034, Russia. t.grishina@spbu.ru.
Andrej FrolovDepartment of Biochemistry, St. Petersburg State University, Saint Petersburg 199034, Russia. afrolov@ipb-halle.de.
Leibniz Institute of Plant Biochemistry · DEMartin Luther University Halle-Wittenberg · DESt Petersburg University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein glycation is a ubiquitous non-enzymatic post-translational modification, formed by reaction of protein amino and guanidino groups with carbonyl compounds, presumably reducing sugars and α-dicarbonyls. Resulting advanced glycation end products (AGEs) represent a highly heterogeneous group of compounds, deleterious in mammals due to their pro-inflammatory effect, and impact in pathogenesis of diabetes mellitus, Alzheimer's disease and ageing. The body of information on the mechanisms and pathways of AGE formation, acquired during the last decades, clearly indicates a certain site-specificity of glycation. It makes characterization of individual glycation sites a critical pre-requisite for understanding in vivo mechanisms of AGE formation and developing adequate nutritional and therapeutic approaches to reduce it in humans. In this context, proteomics is the methodology of choice to address site-specific molecular changes related to protein glycation. Therefore, here we summarize the methods of Maillard proteomics, specifically focusing on the techniques providing comprehensive structural and quantitative characterization of glycated proteome. Further, we address the novel break-through areas, recently established in the field of Maillard research, i.e., in vitro models based on synthetic peptides, site-based diagnostics of metabolism-related diseases (e.g., diabetes mellitus), proteomics of anti-glycative defense, and dynamics of plant glycated proteome during ageing and response to environmental stress.

Indexed as

Maillard ReactionAmino Acid SequenceAnimalsGlycation End Products, AdvancedGlycosylationHumansMass SpectrometryPeptidesProteomeProteomicsGlycation End Products, AdvancedPeptidesProteomeadvanced glycation end products (AGEs)bottom-up proteomicsglycationglyoxalasemodel synthetic peptidesplant glycationpost-translational modificationsproteomics

Identifiers

PMID29231845
PMCPMC5751279
OpenAlexW2773689757

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.